BRIEF published on 10/28/2025 at 13:20, 11 months ago BB Biotech surperforme avec de solides résultats au troisième trimestre 2025 Fusions Et Acquisitions BB Biotech T3 2025 Secteur Des Biotechnologies Indice NASDAQ Biotech
BRIEF published on 10/28/2025 at 13:20, 11 months ago BB Biotech Outperforms with Strong Q3 2025 Results Biotech Sector M&A BB Biotech Q3 2025 Nasdaq Biotech Index
PRESS RELEASE published on 10/28/2025 at 13:15, 11 months ago Edison issues report on BB Biotech (BION) Edison issues positive report on BB Biotech (BION) with strong Q325 results, outperforming its benchmark. Sector outlook remains favorable with M&A as key performance driver Edison M&A BB Biotech Outperforming Q325 Results
BRIEF published on 10/24/2025 at 07:05, 11 months 4 days ago BB Biotech AG Releases Interim Report Highlighting Significant Profit Increase Investment Company BB Biotech AG Interim Report Net Profit Increase Drug Developers
BRIEF published on 10/24/2025 at 07:05, 11 months 4 days ago BB Biotech AG publie un rapport intermédiaire soulignant une augmentation significative des bénéfices BB Biotech AG Société D'investissement Augmentation Du Bénéfice Net Rapport Intermédiaire Développeurs De Médicaments
BRIEF published on 10/24/2025 at 07:05, 11 months 4 days ago Surperformance de BB Biotech au troisième trimestre 2025 dans un contexte de reprise sectorielle BB Biotech Performances Du Troisième Trimestre 2025 Indice Nasdaq Biotechnology Thérapies À Base D'ARN Reprise Du Secteur
BRIEF published on 10/24/2025 at 07:05, 11 months 4 days ago BB Biotech's Q3 2025 Outperformance Amid Sector Recovery Sector Recovery BB Biotech Q3 2025 Performance Nasdaq Biotechnology Index RNA-based Therapeutics
PRESS RELEASE published on 10/24/2025 at 07:00, 11 months 4 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325 Financial Results Investment Company Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/24/2025 at 07:00, 11 months 4 days ago BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
BRIEF published on 09/22/2025 at 07:05, 1 year ago BB Biotech Joins SPI ESG Index Biotechnology Swiss Exchange BB Biotech Sustainable Investing SPI ESG Index
Published on 09/29/2026 at 00:00, 1 hour 5 minutes ago Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
Published on 09/28/2026 at 23:00, 2 hours 5 minutes ago CORRECTION FROM SOURCE: Organto Foods Highlights Record First Half Results and Progress on Key Strategic Initiatives
Published on 09/28/2026 at 15:00, 10 hours 5 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 10 hours 20 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 10 hours 35 minutes ago Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 22:14, 2 hours 51 minutes ago EQS-Adhoc: Extension of the Managing Directors' employment contracts of Carsten Cramer, Lars Ricken and Thomas Treß – Carsten Cramer appointed Chairman of the Management Board
Published on 09/28/2026 at 19:24, 5 hours 40 minutes ago EQS-Adhoc: Hapag-Lloyd further raises its earnings outlook for the current financial year
Published on 09/28/2026 at 19:00, 6 hours 5 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 21 septembre 2026 au 25 septembre 2026
Published on 09/28/2026 at 18:00, 7 hours 5 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 18:00, 7 hours 5 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026
Published on 09/28/2026 at 17:54, 7 hours 10 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 7 hours 10 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:45, 7 hours 20 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 09/28/2026 at 17:35, 7 hours 30 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026
